Michael Kidd

High Impact

Consultant Clinical Scientist

Last publication 2025 Last refreshed 2026-05-16

faculty

38 h-index 123 pubs 5,692 cited

Biography and Research Information

OverviewAI-generated summary

Michael Kidd's research focuses on the development and validation of diagnostic methods for infectious diseases, particularly SARS-CoV-2. His work has investigated the accuracy of various testing platforms, including TaqPath Polymerase Chain Reaction, lateral flow testing, and loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE). He has examined factors influencing test sensitivity, such as testing frequency and population prevalence, and explored their application in both symptomatic and asymptomatic individuals.

Kidd's publications also extend to other medical areas, including a multianalyte liquid biopsy for breast cancer diagnosis and a Phase II trial for recurrent clear cell carcinoma of the ovary. He has contributed to guidelines for the management of HIV-2 and authored a case report on polio virus infection clearance following remdesivir therapy for chronic SARS-CoV-2 infection.

With an h-index of 37 and over 5,600 citations across 123 publications, Kidd is recognized as a highly cited researcher. He leads a research group and collaborates with other scientists, including Inkar Castellanos from the Arkansas Agricultural Experiment Station.

Metrics

  • h-index: 38
  • Publications: 123
  • Citations: 5,692

Selected Publications

  • One Hundred Forty-Seven Years Later: The Avian Influenza Virus H5N1 Goes Wild (2025)
    1 citation DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

184 Collaborators 80 Institutions 9 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics